|
× |
 |
The Alzheimer's Prevention Initiative Composite Cognitive Test Score: Sample Size Estimates for the Evaluation of Preclinical Alzheimer's Disease Treatments in Presenilin 1 E280A Mutation Carriers PDF |
$40.00 |
|
$40.00 |
|
× |
|
Intracerebral Hemorrhages Related to Clinical Conditions and Associated Outcomes Among Saudi and Non-Saudi Patients in a University Hospital: A Retrospective Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
The Use of Statins After a Cardiac Intervention Is Associated With Reduced Risk of Subsequent Depression: Proof of Concept for the Inflammatory and Oxidative Hypotheses of Depression? PDF |
$40.00 |
|
$40.00 |
|
× |
|
Treatments and Treatment Predictors in Patients With Substance Use Disorders and Comorbid Attention-Deficit/Hyperactivity Disorder: First Results From the International Naturalistic Cohort Study of ADHD and SUD (INCAS) PDF |
$40.00 |
|
$40.00 |
|
× |
|
Quantifying the Impact of Patient-Practice Relationship Quality on the Levels of the Average Annual Antidepressant Practice Prescribing Rate in Primary Care in England PDF |
$40.00 |
|
$40.00 |
|
× |
|
Neurological and Psychiatric Manifestations of Cerebral Arteriovenous Malformation: A Case of Hemichorea and Depression PDF |
$40.00 |
|
$40.00 |
|
× |
|
Efficacy and Safety of Desvenlafaxine 50 mg/d in a Randomized, Placebo-Controlled Study of Perimenopausal and Postmenopausal Women With Major Depressive Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Epidemiology of Fears and Specific Phobia in Adolescence: Results From the Mexican Adolescent Mental Health Survey PDF |
$40.00 |
|
$40.00 |
|
× |
|
Generalizability of Clinical Trial Results for Bipolar Disorder to Community Samples: Findings From the National Epidemiologic Survey on Alcohol and Related Conditions PDF |
$40.00 |
|
$40.00 |
|
× |
|
Assessing Psychological Morbidities in Hospital Staff During Nipah Virus Concerns: Prevalence of Depression and Anxiety PDF |
$40.00 |
|
$40.00 |
|
× |
|
Early Placebo Improvement Is a Marker for Subsequent Placebo Response in Long-Acting Injectable Antipsychotic Trials for Schizophrenia: Combined Analysis of 4 RCTs PDF |
$40.00 |
|
$40.00 |
|
× |
|
Early Improvement as a Predictor of Treatment Response in Patients With Obsessive-Compulsive Disorder: A 12-Week Randomized Trial of Sertraline and Fluvoxamine PDF |
$40.00 |
|
$40.00 |
|
× |
|
Commentary: Concerns Regarding the Inclusion of Temper Dysregulation Disorder With Dysphoria in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition PDF |
$40.00 |
|
$40.00 |
|
× |
|
Baseline Characteristics and Early Response at Week 1 Predict Treatment Outcome in Adolescents With Bipolar Manic or Mixed Episode Treated With Olanzapine: Results From a 3-Week, Randomized, Placebo-Controlled Trial PDF |
$40.00 |
|
$40.00 |
|
× |
|
Out of Sight, Out of Mind: The Case of a 62-Year-Old Man With Visual Complaints and Cognitive Decline PDF |
$40.00 |
|
$40.00 |
|
|